person

Gerald Georg W.

Country
Germany
Department
Universitätsmedizin - Klinik für Hämatologie/Med. Onkologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 26 partner sites.

Specializations

Lymphoma Research

The investigator specializes in treating various forms of lymphoma, with particular emphasis on mantle cell lymphoma (MCL) and primary CNS lymphoma. Their expertise extends to innovative treatment approaches for aggressive forms of these conditions.

  • High-risk mantle cell lymphoma management
  • Primary CNS lymphoma treatment strategies
  • Diffuse large B-cell lymphoma

A key focus lies in developing treatment protocols for elderly patients with newly diagnosed lymphomas.

Cell Therapy Innovation

The investigator is actively involved in advancing CAR T-cell therapy applications, particularly focusing on B-cell malignancies. Their work encompasses both pediatric and adult populations requiring innovative cellular treatments.

  • CAR T-cell therapy development
  • B-cell targeted treatments
  • Cellular therapy safety monitoring

Research interests include optimizing cellular therapies for various hematologic conditions.

Stem Cell Transplantation

The investigator's expertise includes autologous stem cell transplantation protocols, particularly in combination with high-dose chemotherapy regimens. Their work focuses on improving transplantation outcomes in complex cases.

  • Age-adjusted transplantation protocols
  • Combined therapy approaches
  • Post-transplant monitoring

Special attention is given to developing optimized conditioning regimens for various patient populations.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.